Cargando…

Interleukin-6 and severity of COVID-19 patients in Hefei, China

• Twenty-four out of 75 patients developed into severe condition in the course of the infection. • The prominent laboratory abnormalities of COVID patients were lymphopenia, elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH). • Elevated interleukin 6 (IL-6) correlated with decrease of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Z., Xie, J., Yin, M., Yang, Y., Ding, C., Gao, Y., Ma, X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316053/ https://www.ncbi.nlm.nih.gov/pubmed/32593746 http://dx.doi.org/10.1016/j.medmal.2020.06.005

Ejemplares similares

Spatial heterogeneity of heavy metal contamination in soils and plants in Hefei, China
por: Zhang, Qianjin, et al.
Publicado: (2019)

Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19
por: Vityala, Yethindra, et al.
Publicado: (2021)

Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries
por: Li, Tao, et al.
Publicado: (2020)

Association between extreme heat and hospital admissions for cataract patients in Hefei, China
por: Xie, Jingui, et al.
Publicado: (2020)

Interleukin-6 as a potential biomarker of COVID-19 progression
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020)

Examining geographical disparities in the incubation period of the COVID-19 infected cases in Shenzhen and Hefei, China
por: Xiao, Zuopeng, et al.
Publicado: (2021)

Psychological Status and Correlated Factors of Primary Medical Staff During the COVID-19 Outbreak in Hefei City, China
por: Wang, Song, et al.
Publicado: (2021)

Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19
por: Gade, Akhil R., et al.
Publicado: (2020)

Comparative analysis of bacterial diversity in two hot springs in Hefei, China
por: Zhang, Feng-Qin, et al.
Publicado: (2023)

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
por: Kow, C.S., et al.
Publicado: (2021)

The Effectiveness of Antiviral Treatment in Severe COVID-19 Patients in Wuhan, China: A Multicenter Study
por: ZHOU, Xian Long, et al.
Publicado: (2022)

The impact of social organizations on HIV/AIDS prevention knowledge among migrants in Hefei, China
por: Wang, Wenting, et al.
Publicado: (2018)

Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease
por: Wang, Renxi
Publicado: (2022)

Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients
por: Touzot, Maxime, et al.
Publicado: (2021)

Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China
por: Cheng, Xiao-wen, et al.
Publicado: (2022)

Construction And Commissioning Of Hefei Synchrotron Radiation source
por: He, Duo-Hui
Publicado: (1990)

Rh-incompatible hemolytic disease of the newborn in Hefei
por: Bi, Shao-Hua, et al.
Publicado: (2019)

Serum vascular endothelial growth factor load and interleukin-6 in cancer patients – reply
por: Salgado, R, et al.
Publicado: (2000)

Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’
por: Kow, Chia Siang, et al.
Publicado: (2023)

Flattening the curve: imperative when China eases the severe COVID-19 control policy
por: Zhao, Shilei, et al.
Publicado: (2023)

Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients
por: Chen, Xiaohua, et al.
Publicado: (2021)

Neurologic manifestations of nonhospitalized patients with COVID‐19 in Wuhan, China
por: Ding, Hong, et al.
Publicado: (2020)

High ambient temperature increases the number of emergency visits for upper urolithiasis in Hefei City, China
por: Sun, Haoxiang, et al.
Publicado: (2023)

Prevalence and correlates of sexual behaviors among university students: a study in Hefei, China
por: Chi, Xinli, et al.
Publicado: (2012)

Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China
por: Huang, Rui, et al.
Publicado: (2022)

A Study on the Soundscape of Underground Commercial Space in Lu’an City and Hefei City, China
por: Wang, Su, et al.
Publicado: (2023)

Re: ‘Non-pharmaceutical intervention strategies for outbreak of COVID-19 in Hangzhou, China’
por: Song, S.J., et al.
Publicado: (2020)

An analysis of cancer patients with asymptomatic infection of SARS-CoV-2 in a cancer center in Wuhan, China
por: Yin, P., et al.
Publicado: (2020)

Ceiling effect of COVID-19 vaccines in China: a retrospective study
por: Peng, Y., et al.
Publicado: (2022)

Characterizing COVID-19 severity, epidemiology and SARS-CoV-2 genotypes in a regional business hub of China
por: Yan, Yan, et al.
Publicado: (2021)

Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?
por: Tailor, Imran K., et al.
Publicado: (2020)

Interleukin-17: A potential therapeutic target in COVID-19
por: Mendoza, Vicky M. Montaño
Publicado: (2020)

Emergence of serogroup C meningococcal disease associated with a high mortality rate in Hefei, China
por: Xu, Xi-Hai, et al.
Publicado: (2012)

Interactive effects of the built environment and rail transit on commuting behavior: Evidence from Hefei, China
por: Yan, Ran, et al.
Publicado: (2023)

Ketamine, Interleukin-6, and Vasoplegia: Is Prevention the Best Medicine?
por: Ortoleva, Jamel P.
Publicado: (2023)

Use of convalescent plasma in COVID-19 patients in China
por: Zhu, M., et al.
Publicado: (2020)

IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Indoor air quality and COVID-19
por: Abouleish, M.Y.Z.
Publicado: (2021)

Association between Meteorological Factors and Outpatient Visits for Herpes Zoster in Hefei, China: A Time-Series Analysis
por: Lv, Xiaojie, et al.
Publicado: (2023)

Mobile health technology combats COVID-19 in China
por: Wu, Jieyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g3bnmbogtkml4k3mnkh9se7qte